Cancer patients with severe symptoms turn to cannabis for relief

This study examined cannabis use patterns among cancer patients receiving palliative care, finding that approximately 11% of palliative care patients self-reported using cannabis products. The research compared symptom profiles between cannabis users and non-users, revealing important patterns about who turns to cannabis during end-of-life care. The data came from 100 cannabis-using patients and 300 non-users evaluated at a major U.S. cancer center in 2024, making this a contemporary snapshot of real-world cannabis adoption in oncology care.

The findings revealed that patients with higher symptom burden were significantly more likely to use cannabis, particularly those experiencing pain, anxiety, and appetite disturbance. Conversely, certain demographics showed lower cannabis use rates: women, older adults, and Black or African American patients reported using cannabis less frequently, suggesting potential disparities in either access, cultural attitudes, or clinical recommendations across different populations. These demographic patterns highlight an important gap in understanding how cannabis is being integrated into cancer care across diverse communities.

The study underscores a critical need for universal screening and patient education about cannabis in palliative care settings. As patients increasingly self-select cannabis to manage multiple symptoms simultaneously, oncology teams need evidence-based guidance to help patients make informed decisions. This research demonstrates that cannabis use in cancer care isn't random—it's driven by specific symptom profiles—making standardized screening and counseling essential components of comprehensive palliative care.